A new report published by Visiongain, has revealed that automation in the biopharma industry is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2033 and the market’s global total revenue will surpass $1,855.0 million in 2023. 📈
This growth in automation in biopharma will be driven by solutions such as robotics and AI.
Want to find out the importance of automated solutions in biopharma? Check this insightful article –Â https://lnkd.in/deVTZGag
